What is more in B cell precursor ALL in children, the presence of CD200/BTLA deletions was associated with poor treatment outcome in patients treated according to the EORTC-CLG 58951 protocol, with inferior event-free survival and overall survival (Ghazavi et al. 2015). The gene discussed is CD200; the disease is acute lymphoblastic leukemia.